Life Sciences Tools and Services
Company Overview of Parabon NanoLabs Inc.
Parabon NanoLabs Inc., a nano-pharmaceutical company, designs and constructs multi-functional macromolecules based on its nanoscale development platform. It develops therapeutics for brain, lung, and breast cancer. The company also develops and licenses its macromolecules for other domain areas, including molecules for nano-sensors for bioweapons defense, nano-arrays for DNA biometrics, and nano-additives for consumer products. In addition, it offers custom nano-design and fabrication services. The company is based in Reston, Virginia. Parabon NanoLabs Inc. operates as a subsidiary of Parabon Computation, Inc.
11260 Roger Bacon Drive
Reston, VA 20190
Key Executives for Parabon NanoLabs Inc.
Founder, President and Chief Executive Officer of Parabon Computation
Compensation as of Fiscal Year 2016.
Parabon NanoLabs Inc. Key Developments
Parabon Nanolabs Receives Two-Year Department of Defense Contract to Develop Novel Software Platform for Forensic Analysis of DNA Evidence
Nov 16 16
Parabon NanoLabs (Parabon) announced the award of a two-year Department of Defense (DoD) contract to develop a novel software platform for forensic analysis of DNA evidence. Many analysis products support traditional DNA typing, however, emerging methods, such as high-throughput DNA sequencing (HTS) and single nucleotide polymorphism (SNP) genotyping, require a collection of bioinformatics capabilities not supported by existing forensic applications. The platform created under this contract, referred to as Keystone, will provide an open architecture that allows bioinformatic data from any forensic science instrument to be analyzed via software plugins that integrate existing analytical tools or implement novel analytical methods. Parabon will develop plugins supporting common workflows, but Keystone's architecture will also enable third parties to develop plugins for particular instruments or analysis. The contract, funded by the Department of Defense Office of the Deputy Assistant Secretary of Defense for Emerging Capabilities and Prototyping, is in response to a DoD Rapid Innovation Fund (RIF) solicitation. The RIF seeks to facilitate the rapid insertion of innovative technologies into military systems or programs that meet critical national security needs. The goal of this effort is to provide DoD DNA laboratories with the latest forensic DNA analysis tools under a single, easy-to-use platform, but Parabon also plans to commercially license Keystone to DNA laboratories around the globe.
Parabon Nanolabs Receives Contract to Aid Identification of Unknown Remains from Past Conflicts
Feb 2 16
Parabon NanoLabs announced that a contract award from the U.S. Army Research Office and the Defense Forensics and Biometrics Agency to extend the range and sensitivity of the company's Snapshot Kinship Inference software for the DoD'sPast Accounting Mission and, more generally, defense-related DNA forensics. Although Snapshot is best known for its DNA phenotyping capabilities (predicting appearance and ancestry from DNA evidence), it also has the ability to accurately predict distant kinship relationships, currently out to six degrees of relatedness (e.g., second cousins once-removed). Under the new contract, Snapshot will be recalibrated on a larger number of reference samples to further improve its accuracy and increase the kinship distances it can predict. Distant kinship inference is an indispensable capability for connecting families with unidentified loved ones who perished in long past conflicts because often the only remaining family members are too genetically distant for traditional DNA analysis to be used. By increasing the genetic distance at which relatedness can be inferred, Snapshot will enable identifications to be made that heretofore have not been possible.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries